Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment

Fig. 2

iPSC-MSCs alleviated airway allergy in vivo and reduced Th2 cytokines dramatically in vitro. a Representative photomicrographs of hematoxylin and eosin (HE)- and periodic acid-Schiff (PAS)-stained lung sections. Original magnification 200×. b The inflammatory infiltration and goblet cell hyperplasia was quantified by HE and PAS scores (n = 6). c Th2 cytokines IL-4 and IL-13 were detected in the supernatant. Memory T (Tm) cells were separated from the spleens of the mice and cultured in vitro (n = 5). **p < 0.01. PBS phosphate-buffered saline, IL interleukin, iPSC-MSC induced pluripotent stem cell-mesenchymal stem cell, OVA ovalbumin

Back to article page